Correspondence on "Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)" by Horak et al
- PMID: 35779071
- DOI: 10.1016/j.gim.2022.05.017
Correspondence on "Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)" by Horak et al
Conflict of interest statement
Conflict of Interest All authors are/were employed by the Mayo Clinic. NM is currently employed by Memorial Sloan Kettering Cancer Center. The authors declare no conflicts of interest.
Comment on
-
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).Genet Med. 2022 May;24(5):986-998. doi: 10.1016/j.gim.2022.01.001. Epub 2022 Jan 29. Genet Med. 2022. PMID: 35101336 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical